A BILL 
To require the Secretary of Health and Human Services 
to promulgate a past due final rule with respect to direct- 
to-consumer prescription drug advertisements, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Banning Misleading 
4
Drug Ads Act of 2022’’. 
5
04:59 Jul 08, 2022
H8289
2 
•HR 8289 IH
SEC. 2. PAST DUE FINAL RULE WITH RESPECT TO DIRECT- 
1
TO-CONSUMER PRESCRIPTION DRUG ADVER-
2
TISEMENTS. 
3
(a) IN GENERAL.—If, by the date that is 180 days 
4
after the date of enactment of this Act, the Secretary of 
5
Health and Human Services has not promulgated a final 
6
rule establishing the standards required by section 
7
901(d)(3)(B) of the Food and Drug Administration 
8
Amendments Act of 2007 (Public Law 110–85), the pro-
9
posed rule titled ‘‘Direct-to-Consumer Prescription Drug 
10
Advertisements; Presentation of the Major Statement in 
11
Television and Radio Advertisements in a Clear, Con-
12
spicuous, and Neutral Manner’’ (75 Fed. Reg. 15376 et 
13
seq.; March 29, 2010) is deemed to be a final rule and 
14
shall have effect beginning on such date. 
15
(b) RULE
OF CONSTRUCTION.—Nothing in sub-
16
section (a) may be construed to prohibit the Secretary 
17
from promulgating, pursuant to the rulemaking authority 
18
of the Secretary under any other provision of law, a 
19
change to, including a replacement of, the rule deemed to 
20
be a final rule under such subsection. 
21
Æ 
04:59 Jul 08, 2022
H8289
